Boson Collider

Bring your deep tech ventures global.

A 12-week VC-led pre-accelerator for Australian deep tech founders. Cohort 1 is now running in Melbourne: fourteen teams across healthcare, AI models, advanced manufacturing and clean tech.

Program12 weeks
ModelVC-led, non-dilutive
Cohort 114 startups · 8+ masters
TimelineOct 2026 – Feb 2027, Melbourne · Demo Day Feb 2027

Supported by

Cohort 1 underway

Why Boson Collider

Australia builds world-class deep tech research. Very little of it becomes a company.

The gap is not the science. It is not knowing who buys it, what they will pay, or how an investor prices the risk you are carrying. That is what the twelve weeks are for.

Cohort 1

Fourteen teams turning research into companies.

Each Cohort 1 team is a Victorian deep tech founder or research spinout. Most are at prototype or MVP stage.

Healthcare & Life Sciences

Bhavira Technologies

Low-cost electrochemical biosensor that detects blood biomarkers for early disease diagnosis.

MM

Moyo Mama

Point-of-care strip test for late-onset preeclampsia, built on a patented biomarker.

OncoRevive

Rapid multiomic blood test for decentralised cancer diagnostics, with results in about two hours.

BioMedika Insights

Stem-cell-derived exosome therapeutics for chronic inflammatory skin conditions.

Tolerix

Regulatory T-cell engineering for autoimmune disease, developing in vivo reprogramming to cut cell-therapy manufacturing cost.

NB

NanoBioCare Pharma

Drug-delivery device for insulin pens.

RL

RespiraLink

Sensor-equipped inhaler spacer that captures objective breathing data in children aged one to five.

AI Models

Navexis

Machine-learning platform that predicts a drug candidate's ADMET behaviour at atom level, before it is synthesised.

X432 Labs

Acoustic AI models of real-world sound under physical conditions, delivered to developers via SDK and API.

Advanced Manufacturing

HN

HyperNetra

Low-cost, real-time hyperspectral imaging that combines insect-eye optics and AI to identify materials in agriculture and manufacturing.

Ecopha Biotech

Patented co-production of sustainable aviation fuel and PHA bioplastics from Pongamia feedstock.

QDT

QDT Ink

Fab-lite short-wave infrared imaging: prints quantum-dot sensors onto standard industrial backplanes, then scales the same process to compact optical receivers.

Clean Tech & Energy

CC

CellCycle

End-of-life solar panel recycling that recovers intact silicon wafers and about 99% of the silver.

ReformEra

Electrified modular reactor that uses electromagnetic heating to convert methane and CO₂ into syngas.

Masters

Learn from masters who have walked each part of the road.

Each master brings deep experience in one part of the journey, from drug development and diagnostics to manufacturing, commercialisation, government and market entry into China.

Dr Xian Bu

Dr Xian Bu

Founder & CEO, SYNthesis Med Chem

Inventor of one of only two FDA-approved small-molecule drugs to originate from Australia, with 16+ drug patents.

Dr Janette Dixon

Dr Janette Dixon

CEO & Founder, JustPartnering

25+ years in CEO and consulting roles. Has founded six biotech companies and specialises in partnering pharmaceutical assets and technologies with multinational pharma.

Leigh Kennedy

Leigh Kennedy

Senior Manager, Startups and Commercialisation, DJSIR

Victorian Department of Jobs, Skills, Industry and Regions, working closely with Innovation Victoria on innovation policy.

Jeff Lang

Jeff Lang

Executive Director, Agentel · CEO, Vortair

35+ years commercialising research IP, advanced materials and manufacturing technologies, with over $200M raised.

Hebbat Manhy

Hebbat Manhy

Executive General Manager, Advanced Manufacturing Readiness Facility (AMRF)

Former Director, Global Manufacturing Operational Excellence at Cochlear; previously at ResMed. Industry Advisory Board, Monash University Faculty of Robotics & Automation. Former Head of Deep Technology, Cicada Innovations.

Dr Dharmica Mistry

Dr Dharmica Mistry

Co-founder & former Chief Scientist, BCAL Diagnostics (ASX)

Board Director, BioNSW. Helped shape Australia's national diagnostics strategy.

Tom Parker

Tom Parker

Former National CEO, Australia China Business Council (ACBC) · Lead, Greater China & North Asia, Global Victoria

Led ACBC, Australia's peak Australia–China business body, as National CEO for three years. Now leads Victoria's trade and investment engagement across Greater China and North Asia.

Allison Rossiter

Allison Rossiter

Independent Non-Executive Director, Clarity Pharmaceuticals (ASX: CU6)

25 years of global leadership across diagnostics, pharma and medtech, most recently as Managing Director of Roche Diagnostics Australia. Chair, SwissCham.

Listed in alphabetical order by surname. More masters to be announced.

Partners

Industry and technical partners in the room.

Cohort 1 teams work directly with global industry and technology leaders through sessions, technical access and introductions.

Listed in alphabetical order.

The Boson toolkits

Two toolkits every team builds on.

Boson's investment team uses the same two tools in due diligence. In Collider, every team builds its own in the Collider portal and keeps refining them for all 12 weeks.

Value Driver Tree

What has to be true for your venture to become highly valuable, broken down until each branch is an assumption you can test. Each branch is rated red, orange or green on the strength of the evidence. You build yours in Week 1, use it to surface technical risk, then map that risk to the investors who can help retire it.

Value Driver Tree in the Collider portal, shown with a demo company

In the Collider portal, illustrated with a demo company (Uber).

Value Chain Mapping

Every player from raw input to end customer, and the money, goods and data that flow between them. You map the chain as it works today, then the positions you could take in it. It shows who to interview, what your market is really worth, and which industry partners are worth your time in the Collider Sessions.

As-is: the chain today

Value Chain Map in the Collider portal, shown with a demo company

To-be: the position you could take

Value Chain Map to-be position in the Collider portal, shown with a demo company

In the Collider portal, illustrated with a demo company (Uber).

What you get

Three things, each with a track record.

01

Industry access that ends in revenue

We introduce you to industry leaders already looking to buy, invest or build in Australia, and we stay in the room until something is signed. Two rounds of one-on-ones, in Week 6 and Week 11.

  • Interview prep and practice before you meet them
  • Named contacts in procurement, engineering and regulatory
  • Industry partners across pharma, robotics and AI, named on this page

What this looked like

US$1M

We introduced a portfolio company to a Chinese listed materials manufacturer. It became a US$1M customer contract, not a memorandum of understanding.

02

An engineer in your R&D loop

Most programs automate your admin. We aim at the research cycle itself: instrumentation, simulation, data pipelines, experiment design. One engineer from a technical partner works with the cohort every week from Week 4.

  • Free consultation and demo access from our technical partners
  • Boson's AI scoping template, applied to your own workflow
  • Technical access through partners including Google, NVIDIA, Alibaba and Huashu Robotics

What this looks like

A scoped build, in one session

You bring the part of your pipeline that eats the most time. You leave with it specced, costed and ready to hand to an engineer.

03

A working route into Asia

Moving Australian technology into Asian markets is what Boson does. For most deep tech, that is where the first paying customer and the manufacturing capacity sit, so it belongs in the plan from Week 1.

  • Asia go-to-market, led by the Boson team in Week 8
  • Landing zones: visiting Hong Kong Science & Technology Parks, China-Singapore Suzhou Industrial Park, NSW-GBA Innovation Channel
  • Cross-border IP, structuring and hiring

After the program

Asian Landing Pad

Graduates can take a partially funded place on the landing pad: a soft-landing base to run the first pilots and partner meetings on the ground.

Inside the 12 weeks

From scientific thesis to investable company.

The program runs in three connected phases. Every session is hands-on, every output is something a founder can take to a customer, an investor, or a board the following week.

Weeks 1–4Phase one

Foundations

Sharpen the thesis. Pressure-test the technical risk, define the wedge, and translate research vocabulary into the language a venture investor and a first customer both understand.

  • Founder identity and team formation
  • Defensible deep tech wedge
  • Market mapping and customer hypotheses
  • Modern AI stack literacy for deep tech founders
Weeks 5–8Phase two

Customer & capital

Run real discovery cycles with named buyers and named investors. Build the financial model, the technical roadmap, and the regulatory plan side by side, not in sequence.

  • Corporate Collider Sessions with industry partners
  • Pricing, unit economics and capital strategy
  • Regulatory, clinical and IP planning by sector
  • APAC go-to-market strategy
Weeks 9–12Phase three

Launch

Turn the work into momentum. Founders close design partners, sharpen the raise narrative, and present to a private investor room at Collider Demo Day.

  • Design-partner agreements and LOIs
  • Investor narrative and data room
  • Collider Demo Day with Boson Ventures and partner funds
  • Post-program founder community
Sector tracks

Built for the sectors where AI rewires real industries.

Boson Collider is for founders building at the intersection of advanced intelligence and three high-leverage sectors. Each track has its own clinics, masters, and customer access.

Track 01

Healthcare & life sciences

Diagnostics, drug discovery, surgical robotics, clinical AI, and intelligent therapeutics — with structured navigation of clinical evidence, reimbursement, and regulatory paths.

Track 02

Advanced manufacturing

Industrial automation, factory perception, materials, and intelligent production systems — paired with operators from Australian and APAC manufacturing.

Track 03

Clean tech & energy

Grid intelligence, energy storage, climate modelling, and the electrification of heavy industry — with clear paths into utility, infrastructure and government channels.

An intentionally broader pipeline

Deep tech moves faster when the founder pool isn't narrow.

Boson Collider is built so the founders who get in actually reflect where the next decade of Australian and APAC deep tech talent will come from — women in STEM, first-generation founders from migrant communities, First Nations entrepreneurs, and researchers building outside the major capital-city innovation hubs.

Blind first-round review

Initial applications are screened without names, institutions, or demographics so the strength of the thesis is what carries through.

Targeted outreach

Active partnership with women-in-STEM networks, multicultural chambers, Indigenous business networks and regional innovation hubs.

Designed for access

Hybrid attendance, recorded sessions, travel support for regional founders, and a pool of masters that reflects the founders we want to attract.

Cohort 2 · Melbourne · 2027

Building deep tech in Victoria? Register your interest for Cohort 2.

Cohort 2 recruitment opens in April 2027, with offers expected around July. Register now and we'll tell you as soon as applications open. You'll also receive Cohort 1 session write-ups as we publish them.

I confirm this startup is based in Victoria, Australia. (Required — Boson Collider is a Victorian Government–backed program.)

Subscribe me to Boson Collider updates.

Thanks — you're on the Cohort 2 list. We'll be in touch when applications open in April 2027.

Oops! Something went wrong while submitting the form.

China market entry

Expanding into China?

Market-entry diligence, customer introductions and on-the-ground support across Shanghai and the Greater Bay Area — open to any Australian tech company, not just our portfolio.

Explore China services →